Here's Why You Should Retain Surmodics (SRDX) Stock for Now 2020/01/07 06:46:00 Zacks Investment Research
Surmodics (SRDX) is gaining from continued strength at Medical Devices unit and persistent efforts to boost R&D functionalities. However, weak performance at Surmodics' IVD unit remains a concern.
Surmodics Reports Fourth Quarter Fiscal 2019 Results and Issues Fiscal 2020 Revenue and EPS Guidance 2019/10/31 20:05:00 Business Wire
EDEN PRAIRIE, Minn.--(BUSINESS WIRE)--Surmodics announced results for its fiscal 2019 fourth quarter ended September 30, 2019, and provided its financial outlook for fiscal 2020.
Will SurModics (SRDX) Gain on Rising Earnings Estimates? 2019/09/12 14:20:04 Zacks Investment Research
SurModics (SRDX) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
Here's Why You Should Invest in Surmodics (SRDX) Stock Now 2019/08/29 08:02:00 Zacks Investment Research
Surmodics (SRDX) is gaining from consistent growth In Vitro Diagnostics (IVD) unit and persistent efforts to boost R&D functionalities.